Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

HKG:2480 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Selling, General & Admin	52.55	64.8	87.01	85.83	60.22
Research & Development	96.48	135.13	172.69	91.43	42.98
Other Operating Expenses	1.55	0.75	0.6	3.14	9.04
Operating Expenses	150.58	200.67	260.3	180.39	112.24
Operating Income	-150.58	-200.67	-260.3	-180.39	-112.24
Interest Expense	-6.58	-0.77	-0.84	-0.72	-0.6
Interest & Investment Income	-	2.84	6.01	0.25	0.04
Earnings From Equity Investments	-0.01	-	-	-	-
Currency Exchange Gain (Loss)	-	1	6.73	1	0
Other Non Operating Income (Expenses)	6.81	18.55	-12.38	-559.41	-437.35
EBT Excluding Unusual Items	-150.36	-179.06	-260.78	-739.28	-550.15
Gain (Loss) on Sale of Investments	-	11.1	11.38	13.87	10.8
Gain (Loss) on Sale of Assets	-	-0.25	0.06	-0	-0.01
Other Unusual Items	-	-0.03	-	0.24	-
Pretax Income	-150.36	-168.24	-249.35	-725.18	-539.36
Net Income	-150.36	-168.24	-249.35	-725.18	-539.36
Net Income to Common	-150.36	-168.24	-249.35	-725.18	-539.36
Shares Outstanding (Basic)	200	202	199	146	91
Shares Outstanding (Diluted)	200	202	199	146	91
Shares Change (YoY)	-0.65%	1.48%	36.65%	60.39%	-
EPS (Basic)	-0.75	-0.83	-1.25	-4.98	-5.94
EPS (Diluted)	-0.75	-0.83	-1.25	-4.98	-5.94
Free Cash Flow	-	-180.45	-275.72	-285.47	-79.08
Free Cash Flow Per Share	-	-0.89	-1.39	-1.96	-0.87
EBITDA	-129.05	-179.15	-248.65	-174.97	-109.42
D&A For EBITDA	21.53	21.53	11.65	5.42	2.83
EBIT	-150.58	-200.67	-260.3	-180.39	-112.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.